425 related articles for article (PubMed ID: 17634104)
1. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis.
Bhasin M; Wu M; Tsirka SE
BMC Immunol; 2007 Jul; 8():10. PubMed ID: 17634104
[TBL] [Abstract][Full Text] [Related]
2. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
3. Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis.
Wu M; Nissen JC; Chen EI; Tsirka SE
PLoS One; 2012; 7(4):e34933. PubMed ID: 22529957
[TBL] [Abstract][Full Text] [Related]
4. Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.
Nissen JC; Tsirka SE
Glia; 2016 Jun; 64(6):923-36. PubMed ID: 26880314
[TBL] [Abstract][Full Text] [Related]
5. Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.
Crocker SJ; Whitmire JK; Frausto RF; Chertboonmuang P; Soloway PD; Whitton JL; Campbell IL
Am J Pathol; 2006 Dec; 169(6):2104-16. PubMed ID: 17148673
[TBL] [Abstract][Full Text] [Related]
6. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
[TBL] [Abstract][Full Text] [Related]
7. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
8. Sex-Specific Effects of Microglia-Like Cell Engraftment during Experimental Autoimmune Encephalomyelitis.
Han J; Zhu K; Zhou K; Hakim R; Sankavaram SR; Blomgren K; Lund H; Zhang XM; Harris RA
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957621
[TBL] [Abstract][Full Text] [Related]
9. MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury.
Storch MK; Weissert R; Steffer A; Birnbacher R; Wallström E; Dahlman I; Ostensson CG; Linington C; Olsson T; Lassmann H
Brain Pathol; 2002 Jul; 12(3):287-99. PubMed ID: 12146797
[TBL] [Abstract][Full Text] [Related]
10. Promotion of microglial phagocytosis by tuftsin stimulates remyelination in experimental autoimmune encephalomyelitis.
Bao Z; Hao J; Li Y; Feng F
Mol Med Rep; 2019 Dec; 20(6):5190-5196. PubMed ID: 31702807
[TBL] [Abstract][Full Text] [Related]
11. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
Hammer LA; Zagon IS; McLaughlin PJ
Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.
Matsushita T; Fujimoto M; Hasegawa M; Komura K; Takehara K; Tedder TF; Sato S
Am J Pathol; 2006 Mar; 168(3):812-21. PubMed ID: 16507897
[TBL] [Abstract][Full Text] [Related]
13. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.
Merkler D; Böscke R; Schmelting B; Czéh B; Fuchs E; Brück W; Stadelmann C
Brain Pathol; 2006 Apr; 16(2):117-23. PubMed ID: 16768751
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
[TBL] [Abstract][Full Text] [Related]
16. Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis.
Lu W; Bhasin M; Tsirka SE
J Neurosci; 2002 Dec; 22(24):10781-9. PubMed ID: 12486171
[TBL] [Abstract][Full Text] [Related]
17. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
18. The adenosine A
Chen Y; Zhang ZX; Zheng LP; Wang L; Liu YF; Yin WY; Chen YY; Wang XS; Hou ST; Chen JF; Zheng RY
Neurochem Int; 2019 Oct; 129():104490. PubMed ID: 31226280
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
20. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis.
Garay LI; González Deniselle MC; Brocca ME; Lima A; Roig P; De Nicola AF
Neuroscience; 2012 Dec; 226():40-50. PubMed ID: 23000619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]